However, it is also possible that additional mechanisms might be engaged in CK2α-promoted ovarian cancer progression as the reconstitution of YAP1 could not completely restored phenotypical changes caused by targeting CK2α in ovarian cancer cells (Fig. 1E–L, Fig. S2C–N). This evidence concerns the gene YAP1 and ovarian cancer.